CompaniesDarwin Molecular

Darwin Molecular

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

3

As Collaborator

0

Total Enrollment

2,233

By Phase

NA: 3

By Status

RECRUITING: 1NOT_YET_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details

Recent Trials

NCT06672692Lead Sponsor
A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients
NARecruiting
1,000 participants
Started: Sep 30, 2024 · Completed: May 31, 2025
NCT06392451Lead Sponsor
LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia
NANot yet recruiting
1,000 participants
Started: May 6, 2024 · Completed: Oct 31, 2024
NCT05897515Lead Sponsor
LIAISON NES Influenza (FLU) A/B & Coronavirus Disease 2019 (COVID-19) Clinical Agreement in Australia
NACompleted
233 participants
Started: Jun 19, 2023 · Completed: Oct 31, 2023
Related Companies
Chiroscience
acquired